Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

danaparoid MeSH Supplementary Concept Data 2025


MeSH Supplementary
danaparoid
Unique ID
C035838
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C035838
Entry Term(s)
Lomoparan
ORG10172
Org 10172
Org-10172
Organon 10172
Orgaran
danaparoid sodium
danaproid
danaproid sodium
Pharm Action
Anticoagulants
Fibrinolytic Agents
Registry Numbers
BI6GY4U9CW
0
5004UU3156
Related Numbers
5004UU3156
83513-48-8
Previous Indexing
*GLYCOSAMINOGLYCANS (82-94)
Heading Mapped to
*Chondroitin Sulfates
*Dermatan Sulfate
*Heparitin Sulfate
Frequency
436
Note
composed of heparan sulfate (83% w/w), dermatan sulfate (12% w/w) and chondroitin sulfate (5% w/w); mixture of sulfated glycosaminoglycorunans derived from hog intestinal mucosa; low MW heparinoid; has anti-factor Xa activity
Source
Thromb Res 1982;27(3):353
Indexing Information
Heparinoids
Date of Entry
1982/10/26
Revision Date
2017/06/16
danaparoid Preferred
Lomoparan Related
Orgaran Related
Org 10172 Narrower
danaparoid sodium Narrower
page delivered in 0.007s